Furiex Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
07 Jul 2014	Form 4: Forest Laboratories, Llc, 10% owner and 1 other Bought 11,169,066 shares ($1.06B)
07 Jul 2014	Form 4: Eshelman Fredric N, Director Returned 2,848,017 shares to the issuer · Disposed of 164,689 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: McIntyre Gail Frances, Senior Vice President-Research Returned 24,318 shares to the issuer · Disposed of 59,350 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Covington Paul S, Senior VP-Clinical Operations Returned 22,523 shares to the issuer · Disposed of 63,944 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Dixon Wendy L, Director Returned 7,160 shares to the issuer · Disposed of 52,570 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Patel Sailash, Chief Financial Officer Returned 26,444 shares to the issuer · Disposed of 84,298 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Corr Peter B, Director Returned 8,447 shares to the issuer · Disposed of 40,470 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Almenoff June Sherie, Director Returned 24,600 shares to the issuer · Disposed of 138,882 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Kaldor Stephen W, Director Returned 7,160 shares to the issuer · Disposed of 31,337 Stock Options (to buy) (Disposition to Issuer)
07 Jul 2014	Form 4: Davis Stephen, Director Returned 9,308 shares to the issuer
26 Jun 2014	Form 4: Patel Sailash, Chief Financial Officer Received 32,928 shares by exercise or conversion ($300K) · Sold 32,928 shares ($3.42M)
26 Jun 2014	Form 4: Covington Paul S, Senior VP-Clinical Operations Received 10,368 shares by exercise or conversion ($185K) · Sold 10,368 shares ($1.08M)
20 Jun 2014	Form 4: Covington Paul S, Senior VP-Clinical Operations Received 45,691 shares by exercise or conversion ($416K) · Sold 45,691 shares ($4.76M)
18 Jun 2014	Form 4: McIntyre Gail Frances, Senior Vice President-Research Sold 66,449 shares ($6.98M) · Received 62,645 shares by exercise or conversion ($739K) · Received 8,008 shares by exercise or conversion ($105K) · 1 more
17 Jun 2014	Form 4: Covington Paul S, Senior VP-Clinical Operations Sold 3,228 shares ($337K)
12 Jun 2014	Form 4: Covington Paul S, Senior VP-Clinical Operations Sold 2,872 shares ($300K)
12 Jun 2014	Form 4: McIntyre Gail Frances, Senior Vice President-Research Sold 1,746 shares ($183K)
12 Jun 2014	Form 4: Patel Sailash, Chief Financial Officer Sold 1,504 shares ($157K)
04 Mar 2014	Form 4: McIntyre Gail Frances, Senior Vice President-Research Received 12,000 shares as a grant or award
04 Mar 2014	Form 4: Patel Sailash, Chief Financial Officer Received 12,000 shares as a grant or award

Comments